Whole-Transcriptome profiling of formalin-fixed, paraffin-embedded renal cell carcinoma by RNA-seq

BMC Genomics

Volumn 15, Issue 1, 2014, Pages

  Li, Ping ^a   Conley, Andrew ^a   Zhang, Hao ^a   Kim, Hyung L ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Formalin fixed paraffin embedded (FFPE); Gene expression; qPCR; Renal cell carcinoma (RCC); RNA seq

Indexed keywords

RIBOSOME RNA; FORMALDEHYDE; PARAFFIN; TUMOR MARKER;

ARTICLE; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; GENE EXPRESSION; GENE EXPRESSION PROFILING; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; KIDNEY CARCINOMA; POLYMERASE CHAIN REACTION; RNA EXTRACTION; RNA FINGERPRINTING; RNA SEQUENCE; CHEMISTRY; CLUSTER ANALYSIS; FREEZING; GENE EXPRESSION REGULATION; GENETICS; HIGH THROUGHPUT SEQUENCING; KIDNEY TUMOR; METABOLISM; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS;

BIOMARKERS, TUMOR; CARCINOMA, RENAL CELL; CLUSTER ANALYSIS; FORMALDEHYDE; FREEZING; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; KIDNEY NEOPLASMS; PARAFFIN EMBEDDING; REAL-TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, RNA;

EID: 84924328760     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-15-1087     Document Type: Article

References (23)

1. Mackay IM, Arden KE, Nitsche A: Real-time PCR in virology. Nucleic Acids Res 2002, 30:1292-1305. 10.1093/nar/30.6.1292.
2. van't Veer LJ, Bernards R: Enabling personalized cancer medicine through analysis of gene-expression patterns. Nature 2008, 452:564-570. 10.1038/nature06915.
3. Arya M, Shergill IS, Williamson M, Gommersall L, Arya N, Patel HR: Basic principles of real-time quantitative PCR. Expert Rev Mol Diagn 2005, 5:209-219. 10.1586/14737159.5.2.209.
4. Wilhelm J, Pingoud A: Real-time polymerase chain reaction. Chembiochem 2003, 4:1120-1128. 10.1002/cbic.200300662.
5. Wong ML, Medrano JF: Real-time PCR for mRNA quantitation. Biotechniques 2005, 39:75-85. 10.2144/05391RV01.
6. Wang Z, Gerstein M, Snyder M: RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet 2009, 10:57-63. 10.1038/nrg2484.
7. Cancer Genome Atlas Research Network: Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature 2013, 499:43-49. 10.1038/nature12222.
8. Tuch BB, Laborde RR, Xu X, Gu J, Chung CB, Monighetti CK, Stanley SJ, Olsen KD, Kasperbauer JL, Moore EJ, Broomer AJ, Tan R, Brzoska PM, Muller MW, Siddiqui AS, Asmann YW, Sun Y, Kuersten S, Barker MA, De La Vega FM, Smith DI: Tumor transcriptome sequencing reveals allelic expression imbalances associated with copy number alterations. PLoS One 2010, 5:e9317. 10.1371/journal.pone.0009317.
9. Guo G, Sun X, Chen C, Wu S, Huang P, Li Z, Dean M, Huang Y, Jia W, Zhou Q, Tang A, Yang Z, Li X, Song P, Zhao X, Ye R, Zhang S, Lin Z, Qi M, Wan S, Xie L, Fan F, Nickerson ML, Zou X, Hu X, Xing L, Lv Z, Mei H, Gao S, Liang C, et al.: Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation. Nat Genet 2013, 45:1459-1463. 10.1038/ng.2798.
10. Maher CA, Kumar-Sinha C, Cao X, Kalyana-Sundaram S, Han B, Jing X, Sam L, Barrette T, Palanisamy N, Chinnaiyan AM: Transcriptome sequencing to detect gene fusions in cancer. Nature 2009, 458:97-101. 10.1038/nature07638.
11. Sinicropi D, Qu K, Collin F, Crager M, Liu ML, Pelham RJ, Pho M, Dei Rossi A, Jeong J, Scott A, Ambannavar R, Zheng C, Mena R, Esteban J, Stephans J, Morlan J, Baker J: Whole transcriptome RNA-Seq analysis of breast cancer recurrence risk using formalin-fixed paraffin-embedded tumor tissue. PLoS One 2012, 7:e40092. 10.1371/journal.pone.0040092.
12. Beck AH, Weng Z, Witten DM, Zhu S, Foley JW, Lacroute P, Smith CL, Tibshirani R, van de Rijn M, Sidow A, West RB: 3'-end sequencing for expression quantification (3SEQ) from archival tumor samples. PLoS One 2010, 5:e8768. 10.1371/journal.pone.0008768.
13. Xiao YL, Kash JC, Beres SB, Sheng ZM, Musser JM, Taubenberger JK: High-throughput RNA sequencing of a formalin-fixed, paraffin-embedded autopsy lung tissue sample from the 1918 influenza pandemic. J Pathol 2013, 229:535-545. 10.1002/path.4145.
14. Hedegaard J, Thorsen K, Lund MK, Hein AM, Hamilton-Dutoit SJ, Vang S, Nordentoft I, Birkenkamp-Demtröder K, Kruhøffer M, Hager H, Knudsen B, Andersen CL, Sørensen KD, Pedersen JS, Ørntoft TF, Dyrskjøt L: Next-generation sequencing of RNA and DNA isolated from paired fresh-frozen and formalin-fixed paraffin-embedded samples of human cancer and normal tissue. PLoS One 2014,9(5):e98187. 10.1371/journal.pone.0098187.
15. Li P, Grigorenko E, Funari V, Enright E, Zhang H, Kim HL: Evaluation of a high-throughput, microfluidics platform for performing TaqMan™ qPCR using formalin-fixed paraffin-embedded tumors. Bioanalysis 2013, 5:1623-1633. 10.4155/bio.13.125.
16. Glenn ST, Jones CA, Liang P, Kaushik D, Gross KW, Kim HL: Expression profiling of archival renal tumors by quantitative PCR to validate prognostic markers. Biotechniques 2007, 43:639-640. 642-643, 647 10.2144/000112562
17. Thompson E, Burt AD, Barker CE, Kirby JA, Brain JG: Development of a robust protocol for gene expression analysis using formalin-fixed, paraffin-embedded liver transplant biopsy specimens. J Clin Pathol 2013, 66:815-818. 10.1136/jclinpath-2013-201548.
18. Takahashi M, Rhodes DR, Furge KA, Kanayama H, Kagawa S, Haab BB, Teh BT: Gene expression profiling of clear cell renal cell carcinoma: gene identification and prognostic classification. Proc Natl Acad Sci U S A 2001, 98:9754-9759. 10.1073/pnas.171209998.
19. Zhao H, Ljungberg B, Grankvist K, Rasmuson T, Tibshirani R, Brooks JD: Gene expression profiling predicts survival in conventional renal cell carcinoma. PLoS Med 2006, 3:e13. 10.1371/journal.pmed.0030013.
20. Vasselli JR, Shih JH, Iyengar SR, Maranchie J, Riss J, Worrell R, Torres-Cabala C, Tabios R, Mariotti A, Stearman R, Merino M, Walther MM, Simon R, Klausner RD, Linehan WM: Predicting survival in patients with metastatic kidney cancer by gene-expression profiling in the primary tumor. Proc Natl Acad Sci U S A 2003, 100:6958-6963. 10.1073/pnas.1131754100.
21. Brannon AR, Reddy A, Seiler M, Arreola A, Moore DT, Pruthi RS, Wallen EM, Nielsen ME, Liu H, Nathanson KL, Ljungberg B, Zhao H, Brooks JD, Ganesan S, Bhanot G, Rathmell WK: Molecular stratification of clear cell renal cell carcinoma by consensus clustering reveals distinct subtypes and survival patterns. Genes Cancer 2010, 1:152-163. 10.1177/1947601909359929.
22. Sato Y, Yoshizato T, Shiraishi Y, Maekawa S, Okuno Y, Kamura T, Shimamura T, Sato-Otsubo A, Nagae G, Suzuki H, Nagata Y, Yoshida K, Kon A, Suzuki Y, Chiba K, Tanaka H, Niida A, Fujimoto A, Tsunoda T, Morikawa T, Maeda D, Kume H, Sugano S, Fukayama M, Aburatani H, Sanada M, Miyano S, Homma Y, Ogawa S: Integrated molecular analysis of clear-cell renal cell carcinoma. Nat Genet 2013, 45:860-867. 10.1038/ng.2699.
23. Glenn ST, Head KL, Teh BT, Gross KW, Kim HL: Maximizing RNA yield from archival renal tumors and optimizing gene expression analysis. J Biomol Screen 2010, 15:80-85. 10.1177/1087057109355059.